Related Experiment Video

Updated: May 28, 2026

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
09:35

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle

Published on: February 1, 2017

Advances in hepatitis C virus vaccines, Part one: Advances in basic knowledge for hepatitis C virus vaccine design

Farzin Roohvand1, Niloufar Kossari

  • 1Pasteur Institute of Iran, Hepatitis & AIDS Department, Pasteur Ave., Tehran, Iran. farzin.roohvand@pasteur.fr

Expert Opinion on Therapeutic Patents
|October 26, 2011
PubMed

Insights

Developing an effective Hepatitis C virus (HCV) vaccine is crucial, as 3% of the global population is infected. Research reviews HCV vaccinology, leading to potential partially effective vaccines for prevention or treatment.

Area of Science:

  • Hepatology and Virology
  • Vaccinology
  • Immunology

Background:

  • Hepatitis C virus (HCV) infects approximately 3% of the global population.
  • HCV infection leads to significant morbidity, including liver cirrhosis and cancer.
  • There is currently no approved vaccine for HCV prevention.

Purpose of the Study:

  • To review current knowledge and advancements in HCV vaccine development.
  • To analyze patent and literature data on HCV genome, proteins, immunology, and animal models.
  • To discuss emerging vaccine formulations, clinical trials, and strategies.

Main Methods:

  • Comprehensive review of patent databases (HCAPLUS) and scientific literature (PubMed).
  • Analysis of HCV genome, proteins, epitopes, and immunological aspects.
  • Evaluation of HCV cell culture systems and animal models.

Main Results:

  • Identification of key viral components and immunological factors relevant to vaccine design.
  • Assessment of various vaccine formulations and delivery methods.
  • Overview of ongoing clinical trials for HCV vaccines.

Conclusions:

  • Advanced understanding of HCV vaccinology supports the development of partially effective vaccines.
  • Novel formulations and modalities are expected to yield vaccines for prevention or treatment.
  • Several promising HCV vaccines are currently in clinical trials.
Abstract

More Related Videos

A Protocol for Analyzing Hepatitis C Virus Replication13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Vaccine Production01:23

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
Human Virome01:26

Human Virome

The human body harbors a vast and diverse viral community known as the human virome. The virome includes bacteriophages that infect bacteria, and eukaryotic viruses that infect human cells. Transient dietary and environmental viruses also contribute to this dynamic ecosystem. Estimates suggest the human body may contain on the order of 10¹³ viral particles, though abundance varies widely by body site and detection method.Comprehensive characterization of the virome has become possible only with...